In vitro and in vivo anti-colon cancer effects of Garcinia mangostana xanthones extract

BMC Complementary and Alternative Medicine

Volumn 12, Issue , 2012, Pages

  Aisha, Abdalrahim F A ^a   Abu Salah, Khalid M ^b   Ismail, Zhari ^a   Majid, AminMalikShahAbdul ^a,c  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GARCINIA MANGOSTANA EXTRACT; MAX PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PLANT EXTRACT; PROTEIN P53; STEM CELL FACTOR; TOLUENE; UNCLASSIFIED DRUG; XANTHONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER INVASION; CELL STRAIN HCT116; CLONOGENESIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; CRYSTALLIZATION; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METASTASIS INHIBITION; MINIMUM INHIBITORY CONCENTRATION; MITOCHONDRION; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; COLONIC NEOPLASMS; GARCINIA MANGOSTANA; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; MICE; MICE, NUDE; PLANT EXTRACTS; SIGNAL TRANSDUCTION; XANTHONES;

EID: 84866603559     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-12-104     Document Type: Article

References (45)

1. Ji X, Avula B, Khan IA. Quantitative and qualitative determination of six xanthones in Garcinia mangostana L. by LC-PDA and LC-ESI-MS. J Pharm Biomed Anal 2007, 43:1270-1276.
2. Harborne JB, Baxter H, Moss GP. Phytochemical dictionary: a handbook of bioactive compounds from plants 1999, CRC, .
3. Pedraza-Chaverri J, Cardenas-Rodriguez N, Orozco-Ibarra M, Perez-Rojas JM. Medicinal properties of mangosteen (Garcinia mangostana). Food Chem Toxicol 2008, 46:3227-3239.
4. Obolskiy D, Pischel I, Siriwatanametanon N, Heinrich M. Garcinia mangostana L.: a phytochemical and pharmacological review. Phytother Res 2009, 23:1047-1065.
5. Cui J, Hu W, Cai Z, Liu Y, Li S, Tao W, Xiang H. New medicinal properties of mangostins: analgesic activity and pharmacological characterization of active ingredients from the fruit hull of Garcinia mangostana L. Pharmacol Biochem Behav 2010, 95:166-172.
6. Jung H, Su B, Keller W, Mehta R, Kinghorn A. Antioxidant xanthones from the pericarp of Garcinia mangostana (Mangosteen). J Agric Food Chem 2006, 54:2077-2082.
7. Chen LG, Yang LL, Wang CC. Anti-inflammatory activity of mangostins from Garcinia mangostana. Food Chem Toxicol 2008, 46:688-693.
8. Akao Y, Nakagawa Y, Iinuma M, Nozawa Y. Anti-cancer effects of xanthones from pericarps of mangosteen. Int J Mol Sci 2008, 9:355-370.
9. Doi H, Shibata MA, Shibata E, MorimotoN J, Akao Y, Iinuma M, Tanigawa N, Otsuki Y. Panaxanthone isolated from pericarp of Garcinia mangostana L. suppresses tumor growth and metastasis of a mouse model of mammary cancer. Anticancer Res 2009, 29:2485-2495.
10. Matsumoto K, Akao Y, Kobayashi E, Ohguchi K, Ito T, Tanaka T, Iinuma M, Nozawa Y. Induction of apoptosis by xanthones from mangosteen in human leukemia cell lines. J Nat Prod 2003, 66:1124-1127.
11. Yoo J-H, Kang K, Jho EH, Chin Y-W, Kim J, Nho CW. [alpha]- and [gamma]-Mangostin Inhibit the Proliferation of Colon Cancer Cells via [beta]-Catenin Gene Regulation in Wnt/cGMP Signalling. Food Chem 2011, 129:1559-1566.
12. Nakatani K, Atsumi M, Arakawa T, Oosawa K, Shimura S, Nakahata N, Ohizumi Y. Inhibitions of histamine release and prostaglandin E2 synthesis by mangosteen, a Thai medicinal plant. Biol Pharm Bull 2002, 25:1137-1141.
13. Sakagami Y, Iinuma M, Piyasena KG, Dharmaratne HR. Antibacterial activity of alpha-mangostin against vancomycin resistant Enterococci (VRE) and synergism with antibiotics. Phytomedicine 2005, 12:203-208.
14. Suksamrarn S, Suwannapoch N, Phakhodee W, Thanuhiranlert J, Ratananukul P, Chimnoi N, Suksamrarn A. Antimycobacterial activity of prenylated xanthones from the fruits of Garcinia mangostana. Chem Pharm Bull(Tokyo) 2003, 51:857-859.
15. Kaomongkolgit R, Jamdee K, Chaisomboon N. Antifungal activity of alpha-mangostin against Candida albicans. J Oral Sci 2009, 51:401-406.
16. Chen S, Wan M, Loh B. Active constituents against HIV-1 protease from Garcinia mangostana. Planta Med 1996, 62:381-382.
17. Devi Sampath P, Vijayaraghavan K. Cardioprotective effect of alpha-mangostin, a xanthone derivative from mangosteen on tissue defense system against isoproterenol-induced myocardial infarction in rats. J Biochem Mol Toxicol 2007, 21:336-339.
18. Weecharangsan W, Opanasopit P, Sukma M, Ngawhirunpat T, Sotanaphun U, Siripong P. Antioxidative and neuroprotective activities of extracts from the fruit hull of mangosteen (Garcinia mangostana Linn.). Med Princ Pract 2006, 15:281-287.
19. Tang YP, Li PG, Kondo M, Ji HP, Kou Y, Ou B. Effect of a mangosteen dietary supplement on human immune function: a randomized, double-blind, placebo-controlled trial. J Med Food 2009, 12:755-763.
20. Global Cancer Facts & Figures 2011, American Cancer Society, Atlanta, 2.
21. Cancer Fact sheet N°297. In Book Cancer Fact sheet N°297 2011, World Health Organization, .
22. Johnson JJ, Petiwala SM, Syed DN, Rasmussen JT, Adhami VM, Siddiqui IA, Kohl AM, Mukhtar H. α-Mangostin, a xanthone from mangosteen fruit, promotes cell cycle arrest in prostate cancer and decreases xenograft tumor growth. Carcinogenesis 2012, 33:413-419.
23. Jost LM, Kirkwood JM, Whiteside TL. Improved short- and long-term XTT-based colorimetric cellular cytotoxicity assay for melanoma and other tumor cells. J Immunol Methods 1992, 147:153-165.
24. Aisha AFA, Sahib HB, Abu-Salah KM, Darwis Y, Abdul Majid AMS. Cytotoxic and anti-angiogenic properties of the stem bark extract of Sandoricum koetjape. Int J Cancer Res 2009, 5:105-114.
25. Cheah YH, Azimahtol HL, Abdullah NR. Xanthorrhizol exhibits antiproliferative activity on MCF-7 breast cancer cells via apoptosis induction. Anticancer Res 2006, 26:4527-4534.
26. Johnson LV, Walsh ML, Chen LB. Localization of mitochondria in living cells with rhodamine 123. Proc Natl Acad Sci USA 1980, 77:990-994.
27. Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. Clonogenic assay of cells in vitro. Nat Protoc 2006, 1:2315-2319.
28. Liang CC, Park AY, Guan JL. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2007, 2:329-333.
29. Shaw LM. Tumor cell invasion assays. Methods Mol Biol 2005, 294:97-105.
30. Tomayko MM, Reynolds CP. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 1989, 24:148-154.
31. Kopper L, Steel GG. The therapeutic response of three human tumor lines maintained in immune-suppressed mice. Cancer Res 1975, 35:2704-2713.
32. Fodstad O, Aamdal S, Pihl A, Boyd MR. Activity of mitozolomide (NSC 353451), a new imidazotetrazine, against xenografts from human melanomas, sarcomas, and lung and colon carcinomas. Cancer Res 1985, 45:1778-1786.
33. Rajput A, Dominguez San Martin I, Rose R, Beko A, Levea C, Sharratt E, Mazurchuk R, Hoffman RM, Brattain MG, Wang J. Characterization of HCT116 human colon cancer cells in an orthotopic model. J Surg Res 2008, 147:276-281.
34. Matsumoto K, Akao Y, Yi H, Ohguchi K, Ito T, Tanaka T, Kobayashi E, Iinuma M, Nozawa Y. Preferential target is mitochondria in alpha-mangostin-induced apoptosis in human leukemia HL60 cells. Bioorg Med Chem 2004, 12:5799-5806.
35. Hung SH, Shen KH, Wu CH, Liu CL, Shih YW. Alpha-mangostin suppresses PC-3 human prostate carcinoma cell metastasis by inhibiting matrix metalloproteinase-2/9 and urokinase-plasminogen expression through the JNK signaling pathway. J Agric Food Chem 2009, 57:1291-1298.
36. Cagnol S, Chambard JC. ERK and cell death: mechanisms of ERK-induced cell death-apoptosis, autophagy and senescence. FEBS J 2010, 277:2-21.
37. Nilsson JA, Cleveland JL. Myc pathways provoking cell suicide and cancer. Oncogene 2003, 22:9007-9021.
38. Wang X, Martindale JL, Holbrook NJ. Requirement for ERK activation in cisplatin-induced apoptosis. J Biol Chem 2000, 275:39435-39443.
39. Stefanelli C, Tantini B, Fattori M, Stanic I, Pignatti C, Clo C, Guarnieri C, Caldarera CM, Mackintosh CA, Pegg AE, Flamigni F. Caspase activation in etoposide-treated fibroblasts is correlated to ERK phosphorylation and both events are blocked by polyamine depletion. FEBS Lett 2002, 527:223-228.
40. Tang D, Wu D, Hirao A, Lahti JM, Liu L, Mazza B, Kidd VJ, Mak TW, Ingram AJ. ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53. J Biol Chem 2002, 277:12710-12717.
41. Ravi RK, Weber E, McMahon M, Williams JR, Baylin S, Mal A, Harter ML, Dillehay LE, Claudio PP, Giordano A, et al. Activated Raf-1 causes growth arrest in human small cell lung cancer cells. J Clin Invest 1998, 101:153-159.
42. Chen J, Peng H, Ou-Yang X, He X. Research on the antitumor effect of ginsenoside Rg3 in B16 melanoma cells. Melanoma Res 2008, 18:322-329.
43. Sahu RP, Zhang R, Batra S, Shi Y, Srivastava SK. Benzyl isothiocyanate-mediated generation of reactive oxygen species causes cell cycle arrest and induces apoptosis via activation of MAPK in human pancreatic cancer cells. Carcinogenesis 2009, 30:1744-1753.
44. Hardwick JC, van den Brink GR, Offerhaus GJ, van Deventer SJ, Peppelenbosch MP. NF-kappaB, p38 MAPK and JNK are highly expressed and active in the stroma of human colonic adenomatous polyps. Oncogene 2001, 20:819-827.
45. Krajarng A, Nakamura Y, Suksamrarn S, Watanapokasin R. alpha-Mangostin Induces Apoptosis in Human Chondrosarcoma Cells through Downregulation of ERK/JNK and Akt Signaling Pathway. J Agric Food Chem 2011, 59:5746-5754.